[O8] Oral Session 8"Cell therapy 1"

[O8-5] Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers

^○Thanyavi Chinsuwan^1,2, Koichi Hirabayashi², Shuji Mishima³, Aiko Hasegawa², Miyuki Tanaka^2,4, Hidemi Mochizuki^4,5, Akihito Shimoi^4,5, Takashi Murakami⁶, Shigeki Yagyu^2,4, Kimihiro Shimizu³, Yozo Nakazawa^2,4,7 (1.Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, 2.Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Nagano, Japan, 3.Division of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano, Japan, 4.Center for Advanced Research of Gene and Cell Therapy, Shinshu University School of Medicine, Matsumoto, Nagano, Japan, 5.Ina Research Inc., Ina, Nagano, Japan, 6.Department of Microbiology, Faculty of Medicine, Saitama Medical University, Iruma, Saitama, Japan, 7.Institute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University, Matsumoto, Nagano, Japan)